doi: 10.1016/j.ejim.2016.04.024.
Epub 2016 May 11.
Obstructive Lung Diseases and Beta-Blockers: Where Do We Stand?
Affiliations
- PMID: 27179413
- DOI: 10.1016/j.ejim.2016.04.024
Item in Clipboard
Obstructive Lung Diseases and Beta-Blockers: Where Do We Stand?
Eur J Intern Med.
.
Abstract
No abstract availableKeywords: Asthma; Atrial fibrillation; Beta-blocker; Chronic obstructive pulmonary disease; Coronary artery disease; Heart failure.
Similar articles
-
[Obstructive respiratory tract diseases: contraindications to beta blockers crumble].MMW Fortschr Med. 2014 Mar 6;156(4):24. MMW Fortschr Med. 2014. PMID: 24908761 German. No abstract available.
-
Role of beta-blocker therapy in heart failure and atrial fibrillation.Card Electrophysiol Rev. 2003 Sep;7(3):236-42. doi: 10.1023/B:CEPR.0000012390.43937.2c. Card Electrophysiol Rev. 2003. PMID: 14739721 Review.
-
[Beta-blocker prescription and chronic obstructive pulmonary disease].Ann Cardiol Angeiol (Paris). 2007 Nov;56(5):231-6. doi: 10.1016/j.ancard.2006.08.002. Epub 2006 Sep 11. Ann Cardiol Angeiol (Paris). 2007. PMID: 17854758 Review. French.
-
[Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].Internist (Berl). 2004 Feb;45(2):221-7. doi: 10.1007/s00108-003-1093-3. Internist (Berl). 2004. PMID: 14991165 Review. German.
-
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2. Lancet. 2014. PMID: 25193873
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
